Regeneron Pharmaceuticals
REGN
#269
Rank
โ‚น7.445 T
Marketcap
โ‚น70,245
Share price
-0.19%
Change (1 day)
15.92%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚น446.36 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.24 Billion. In 2024 the company made an earning of โ‚น428.42 Billion, an increase over its 2023 earnings that were of โ‚น376.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น446.36 B4.19%
2024 โ‚น428.42 B13.83%
2023 โ‚น376.38 B-13.57%
2022 โ‚น435.49 B-47.9%
2021 โ‚น835.88 B144.75%
2020 โ‚น341.52 B56.86%
2019 โ‚น217.72 B-4.87%
2018 โ‚น228.87 B22.86%
2017 โ‚น186.29 B56.3%
2016 โ‚น119.19 B8.55%
2015 โ‚น109.80 B54.53%
2014 โ‚น71.05 B11.14%
2013 โ‚น63.93 B72.13%
2012 โ‚น37.14 B-285.93%
2011 -โ‚น19.98 Billion121.73%
2010 -โ‚น9.02 Billion37.18%
2009 -โ‚น6.57 Billion-14.6%
2008 -โ‚น7.7 Billion-25.02%
2007 -โ‚น10.26 Billion6.32%
2006 -โ‚น9.65 Billion-186.52%
2005 โ‚น11.15 B2103.7%
2004 โ‚น0.50 B-105.66%
2003 -โ‚น8.95 Billion-18.18%
2002 -โ‚น10.94 Billion42.33%
2001 -โ‚น7.68 Billion129.35%
2000 -โ‚น3.35 Billion51.87%
1999 -โ‚น2.21 Billion92.19%
1998 -โ‚น1.15 Billion66.23%
1997 -โ‚น0.7 Billion-55.49%
1996 -โ‚น1.56 Billion103.53%
1995 -โ‚น0.77 Billion-70.89%
1994 -โ‚น2.62 Billion-26.08%
1993 -โ‚น3.55 Billion114.67%
1992 -โ‚น1.65 Billion196.77%
1991 -โ‚น0.56 Billion87.88%
1990 -โ‚น0.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น738.91 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.68 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น170.65 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.903 T 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.471 T 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น815.66 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France